Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
You need to see inside the vial clearly to confirm the powder has fully dissolved and no particles remain
Insulin resistance and PCOS: Patients with severe insulin resistance or polycystic ovary syndrome (PCOS) may have a more complex metabolic profile that requires additional intervention beyond GLP-1 therapy alone
Others, like tirzepatide, act on both GIP and GLP-1 receptors
Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk
Taken as a once-daily oral capsule
doi:10.1038/SJ.IJO.0801250 62
